Our latest news
Professor Gérard SAILLANT, President of Paris Brain Institute, extends his warmest wishes to all those who, by faithfully supporting the research carried out at the institute, enable us to make a tangible difference in our fight against brain...
01.08.2025
Institutional
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025
Research, science & health
Appointed Executive Director of Paris Brain Institute for a five-year term, Professor Stéphanie Debette took up her new position on January 1, 2025. She succeeds Professor Alexis Brice, who has served as Executive Director since 2012.
01.07.2025
Institutional
Paris, December 11, 2024. Identifying and supporting innovative neuroscience projects up to the creation of viable startups: this is the mission of iPEPS, Paris Brain Institute's startup studio. Through the NeurAL program, launched in 2023 and...
01.02.2025
Research applications
This week, Paris Brain Institute inaugurated an exceptional piece of equipment: the latest generation 7-Tesla MAGNETOM Terra.X MRI scanner from Siemens Healthineers. This acquisition, made possible thanks to the support of RICHARD MILLE and the...
11.28.2024
Institutional
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024
Research, science & health
Research at Paris Brain Institute
Since its creation, Paris Brain Institute has placed patients at the heart of its scientific and medical strategy.
-
846 Staff including 83% scientific, medical and paramedical staff (as at September 30, 2023)
-
29 Research teams selected by a Scientific Advisory Board
-
45 Nationalities (as at September 30, 2023)
-
12 Technical facilities and biobank
Understanding the brain
Every day, scientific research makes it possible to learn a little more about the brain, the seat of cognition, memory and emotions. From the anatomy of the brain to current knowledge about consciousness and various neurological diseases, discover...
With nearly 860 000 people suffering from Alzheimer type dementia in France, this disease is now a central focus. It is characterised by slow neuron degeneration beginning at the level of a specific area and then extending to the rest of the brain.
Parkinson's disease is the most common neurodegenerative disease after Alzheimer's and the first cause of parkinsonian syndrome.
Multiple sclerosis (MS) is the 2nd leading cause of acquired disability in young adults, after trauma. It currently affects 120,000 people in France, with 3,000 new cases diagnosed each year. The disease is a major public health issue, as it affects...
Amyotrophic Lateral Sclerosis (ALS) or ‘Charcot's Disease’ is a progressive and fatal neuromuscular pathology characterised by the progressive death of motor neurons, the neurons that control walking, speech, swallowing and breathing, among other...
A tumour is formed by cells that multiply uncontrollably, hijacking surrounding cells and, to varying degrees, disrupting brain function. A brain tumour can develop in any area of the brain.
The name ‘epilepsy’ comes from a Greek word meaning ‘struck by surprise’, reflecting the sudden and unpredictable onset of seizures. In France, 600,000 people are affected by this chronic neurological disease, which can manifest itself in different...
A cerebrovascular accident or stroke is a pathology that occurs very suddenly and causes motor deficits (movement of the limbs), loss of feeling or language problems.
Autism or autism spectrum disorder is a neurodevelopmental disorder with two main symptoms: persistent deficits in communication and social interaction in a variety of contexts, and restricted and repetitive behaviour, interests and activities.
Mental health, an essential component of health, is a state of well-being, an ability of the mind to function normally and respond appropriately to environmental stimuli. Mental disorders occur when this state of well-being is disrupted by specific...
Tourette's syndrome (TS) was first described in the 19th century by the French neurologist Georges Gilles de la Tourette. It is a neuropsychiatric disorder with a genetic component characterised by sudden, brief and intermittent movements (motor tics...
Although the word ' bipolar' is increasingly used in the media these days, and is sometimes misused, there is a serious and debilitating pathology behind this term, which affects almost 3% of the population.
How support Paris Brain Institute?
And commit to it
-
Ten reasons to support Paris Brain Institute
Find out why we support Paris Brain Institute -
Provide direct and regular support for research
Find out how to make a monthly donation -
Transfer all or part of your estate to the Institute
Discover the different transmission modes -
Involving a company in the Institute's research mission
Find out how to become a corporate partner or sponsor